Marksans Pharma Ltd (MARKSANS) — Announcement | 1 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Marksans Pharma to host investor/analyst meet on September 2, 2026
💡 Investor Takeaway
The meet provides a platform for shareholders to hear directly from management on growth plans and sector outlook.

Marksans Pharma announced its participation in an investor/analyst meet on September 2, 2026, at Hyatt, Santacruz East, Mumbai, as part of the India Dialogue 2026 event, with no unpublished price sensitive information to be shared.

📄 View Original Announcement (PDF)

About Marksans Pharma Ltd (MARKSANS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹14,612.26 Cr P/E: 28.3 ROE: 17.2% ROCE: 23.4% Div Yield: 0.28%

View full MARKSANS stock details →

📡 Get AI alerts when MARKSANS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MARKSANS — Free

📊 More MARKSANS filings

See all MARKSANS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MARKSANS files new disclosures

Track MARKSANS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MARKSANS — Free

Free account · 2 AI queries/day